These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 10753194)
1. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate. Rao CV; Cooma I; Rodriguez JG; Simi B; El-Bayoumy K; Reddy BS Carcinogenesis; 2000 Apr; 21(4):617-21. PubMed ID: 10753194 [TBL] [Abstract][Full Text] [Related]
2. Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and beta-catenin pathways in colon cancer cells. Narayanan BA; Narayanan NK; Desai D; Pittman B; Reddy BS Carcinogenesis; 2004 Dec; 25(12):2443-9. PubMed ID: 15297372 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity. Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834 [TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of colon carcinogenesis by the synthetic organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Reddy BS; Rivenson A; Kulkarni N; Upadhyaya P; el-Bayoumy K Cancer Res; 1992 Oct; 52(20):5635-40. PubMed ID: 1394188 [TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diets. Reddy BS; Rivenson A; El-Bayoumy K; Upadhyaya P; Pittman B; Rao CV J Natl Cancer Inst; 1997 Apr; 89(7):506-12. PubMed ID: 9086007 [TBL] [Abstract][Full Text] [Related]
7. Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Jacoby RF; Cole CE; Tutsch K; Newton MA; Kelloff G; Hawk ET; Lubet RA Cancer Res; 2000 Apr; 60(7):1864-70. PubMed ID: 10766173 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms in the chemoprevention of colon cancer: modulation of protein kinase C, tyrosine protein kinase and diacylglycerol kinase activities by 1,4-phenylenebis-(methylene)selenocyanate and impact of low-fat diet. Rao CV; Simi B; Hirose Y; Upadhyaya P; El-Bayoumy K; Reddy BS Int J Oncol; 2000 Mar; 16(3):519-27. PubMed ID: 10675484 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the chemopreventive efficacies of 1,4-phenylenebis(methylene)selenocyanate and selenium-enriched yeast on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced lung tumorigenesis in A/J mouse. Das A; Desai D; Pittman B; Amin S; El-Bayoumy K Nutr Cancer; 2003; 46(2):179-85. PubMed ID: 14690794 [TBL] [Abstract][Full Text] [Related]
10. 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Tanaka T; Makita H; Kawabata K; Mori H; El-Bayoumy K Cancer Res; 1997 Sep; 57(17):3644-8. PubMed ID: 9288763 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis. Kawamori T; El-Bayoumy K; Ji BY; Rodriguez JG; Rao CV; Reddy BS Int J Oncol; 1998 Jul; 13(1):29-34. PubMed ID: 9625800 [TBL] [Abstract][Full Text] [Related]
12. Prevention of familial adenomatous polyp development in APC min mice and azoxymethane-induced colon carcinogenesis in F344 Rats by ω-3 fatty acid rich perilla oil. Rao CV; Patlolla JM; Cooma I; Kawamori T; Steele VE Nutr Cancer; 2013; 65 Suppl 1():54-60. PubMed ID: 23682783 [TBL] [Abstract][Full Text] [Related]
13. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063 [TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of familial adenomatous polyposis by bromo-noscapine (EM011) in the Apc(Min/+) mouse model. Li S; Ghaleb AM; He J; Bughani U; Bialkowska AB; Yang VW; Joshi HC Int J Cancer; 2012 Sep; 131(6):1435-44. PubMed ID: 22052467 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. Swamy MV; Patlolla JM; Steele VE; Kopelovich L; Reddy BS; Rao CV Cancer Res; 2006 Jul; 66(14):7370-7. PubMed ID: 16849589 [TBL] [Abstract][Full Text] [Related]
16. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of lung tumorigenesis induced by a mixture of benzo(a)pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Prokopczyk B; Rosa JG; Desai D; Amin S; Sohn OS; Fiala ES; El-Bayoumy K Cancer Lett; 2000 Dec; 161(1):35-46. PubMed ID: 11078911 [TBL] [Abstract][Full Text] [Related]
19. Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level. Hsi LC; Angerman-Stewart J; Eling TE Carcinogenesis; 1999 Nov; 20(11):2045-9. PubMed ID: 10545404 [TBL] [Abstract][Full Text] [Related]
20. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]